NCT03807219View on ClinicalTrials.gov

The Study of Efficacy and Safety of a 60-day Use of the Magnox Comfort Compared to the Placebo in Subjects With NLC

NACompletedINTERVENTIONAL
Enrollment

216

Participants

Timeline

Start Date

February 9, 2018

Primary Completion Date

August 27, 2018

Study Completion Date

August 27, 2018

Conditions
Nocturnal Leg Cramps
Interventions
DIETARY_SUPPLEMENT

Magnox Comfort

Magnox Comfort (Magnesium (226 mg in equivalent), Vitamin E - 45 mg, Vitamin B6 - 2 mg.).

OTHER

Placebo

placebo

Trial Locations (7)

Unknown

Kharkiv City Clinic №9, Kharkiv

Kyiv city clinic №9, Kyiv

"Medical Center Artem", Kyiv

"Medical Center Preventclinic LLC", Kyiv

City clinic №5, Lviv

Odesa Railway City Clinic, Odesa

"Medical center Desna LLC", Ternopil

Sponsors

Lead Sponsor

Naveh Pharma LTD
All Listed Sponsors
lead

Naveh Pharma LTD

INDUSTRY

NCT03807219 - The Study of Efficacy and Safety of a 60-day Use of the Magnox Comfort Compared to the Placebo in Subjects With NLC | Biotech Hunter | Biotech Hunter